HPV for Cervical Cancer Screening
Open Access
- 1 September 2001
- journal article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 49 (9), 1197-1198
- https://doi.org/10.1177/002215540104900918
Abstract
Based on the best estimates of the prevalence of human Papillomavirus infection in the United States, the overall HPV prevalence in the target population is approximately 20%. The prevalence varies greatly with age, being as high as ∼50% in the third decade to less than 5% in the sixth. These data have implications for a discussion about the utility of human Papillomavirus testing as a screening procedure. (J Histochem Cytochem 49:1197–1198, 2001)Keywords
This publication has 8 references indexed in Scilit:
- Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized TrialJNCI Journal of the National Cancer Institute, 2001
- Advances in Cervical Screening TechnologyLaboratory Investigation, 2000
- Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized TrialJNCI Journal of the National Cancer Institute, 2000
- HPV DNA Testing in Cervical Cancer ScreeningJAMA, 2000
- Human Papillomaviruses and Cervical Neoplasia: A Model for CarcinogenesisInternational Journal of Gynecological Pathology, 2000
- ASCUS-LSIL Triage StudyActa Cytologica, 2000
- Identifying Women With Cervical NeoplasiaJAMA, 1999
- Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectivenessBritish Journal of Cancer, 1997